Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 09, 2019

SELL
$178.02 - $225.69 $1,068 - $1,354
-6 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$176.18 - $248.92 $16.8 Million - $23.7 Million
-95,255 Reduced 99.99%
6 $1,000
Q3 2018

Nov 13, 2018

SELL
$218.82 - $254.46 $10.7 Million - $12.5 Million
-49,057 Reduced 33.99%
95,261 $23.8 Million
Q2 2018

Aug 09, 2018

SELL
$185.56 - $227.9 $7.22 Million - $8.87 Million
-38,904 Reduced 21.23%
144,318 $31.5 Million
Q1 2018

May 14, 2018

SELL
$157.81 - $204.73 $7.64 Million - $9.91 Million
-48,382 Reduced 20.89%
183,222 $35.1 Million
Q4 2017

Feb 09, 2018

SELL
$147.68 - $168.37 $10.2 Million - $11.6 Million
-69,096 Reduced 22.98%
231,604 $36.2 Million
Q3 2017

Nov 13, 2017

SELL
$150.32 - $166.46 $2.34 Million - $2.6 Million
-15,600 Reduced 4.93%
300,700 $46.8 Million
Q2 2017

Aug 07, 2017

BUY
N/A
316,300
316,300 $51.1 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $33.9B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.